Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Mundipharma and Endoceutics to Exclusively License Intrarosa™ (Prasterone) in MEA Region

Monday, May 21, 2018

A unique nonestrogen prescription therapy Intrarosa has been approved by the US Food and Drug Administration FDA and by the European Medical Agency EMA for the treatment of the most bothersome symptom of vulvovaginal atrophy due to menopause known as dyspareunia Mundipharma has been granted the c..

Pivot Signs Manufacturing and Supply Agreement With California-Based Stoney LLC

Friday, May 18, 2018

Pivot Pharmaceuticals Inc is pleased to announce that its whollyowned California subsidiary Pivot Naturals LLC has signed a Definitive Manufacturing and Supply Agreement the Agreement with Stoney LLC Stoney a leading brand of cannabis products in the state of California Under the terms of the Agr..

Dipharma Francis S.r.l. completes acquisition of Kalexsyn, Inc.

Friday, May 18, 2018

Dipharma Francis Srl a leading European manufacturer of Active Pharmaceutical Ingredients is pleased to communicate that it has completed its previously announced acquisition of Kalexsyn Inc Kalexsyn a worldclass Contract Research Organization CRO providing chemistry services to the biotechnology an..

Emulate, Inc. and AstraZeneca Form Strategic Agreement to Work Side-by-Side on Organs-on-Chips Technology

Thursday, May 17, 2018

Emulate Inc has formed a collaborative partnership with AstraZenecas Innovative Medicines and Early Development IMED Biotech Unit to embed its OrgansonChips technology within the laboratories of the IMED Drug Safety organization As part of the agreement Emulate plans to colocate scientists within As..

Turnstone Biologics Announces U.S. FDA Acceptance of IND for Immunotherapy Targeting HPV Positive Cancers

Thursday, May 17, 2018

Turnstone Biologics today announced it has received US Food and Drug Administration FDA clearance of its Investigational New Drug Application IND for MG1HPV for the treatment of patients with human papillomavirus HPV positive solid tumors Additionally Turnstone today announced that it has entered in..

BioLamina and Novo Nordisk Partner to Advance Stem Cell Based Therapies for Three Common Medical Conditions

Wednesday, May 16, 2018

BioLamina and collaborators have partnered with Novo Nordisk AS Novo Nordisk a Danish multinational pharmaceutical company allowing Novo Nordisk to develop novel stem cell based therapies based on Biolaminins human recombinant laminin cell culture matrices developed and produced by BioLamina Novo..

Lilly to Acquire AurKa Pharma

Tuesday, May 15, 2018

Eli Lilly and Company announced an agreement to acquire AurKa Pharma Inc a company established by TVM Capital Life Science to develop oncology compound AK01 an Aurora kinase A inhibitor that was originally discovered at Lilly The compound is a potential firstinclass asset that AurKa Pharma is studyi..

Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies

Tuesday, May 15, 2018

Zymeworks Inc a clinicalstage biopharmaceutical company developing multifunctional therapeutics and Daiichi Sankyo Company Limited Daiichi Sankyo announced today that they entered into a new license agreement building upon their 2016 crosslicensing and collaboration agreement With a successful tr..

AstraZeneca's drug Fasenra flops in COPD trial

Monday, May 14, 2018

AstraZenecas said its first respiratory biologic medicine Fasenra failed to meet its target in a clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease COPD The drug is currently approved as an addon treatment for severe eosinophilic asthma in the Unit..

Lilly Announces Agreement To Acquire ARMO BioSciences

Friday, May 11, 2018

Eli Lilly and Company and ARMO BioSciences Inc announced a definitive agreement for Lilly to acquire ARMO for 50 per share or approximately 16 billion in an allcash transaction ARMO BioSciences is a latestage immunooncology company that is developing a pipeline of novel proprietary product candidate..